Literature DB >> 2826651

Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis.

J Krubke1, J Kraus, H Delius, L Chow, T Broker, T Iftner, H Pfister.   

Abstract

Human papillomaviruses (HPVs) 5, 8, 19 and 25 induce macular skin lesions in patients with epidermodysplasia verruciformis. HPVs 5 and 8 are known to prevail in skin carcinomas, which develop in about one-third of these patients. We compared the viral DNAs by heteroduplex analysis and on the basis of partial nucleotide sequences. The colinear genomes were closely related and showed nucleotide sequence homology in the range of 40% to 90%. Homology values between 70% and 80% were observed throughout roughly 4 kb of the heteroduplex molecules as estimated after 'calibration' by partial sequencing. Heteroduplex analysis did not support the hypothesis that the different HPV types arise by recombination and allowed no grouping to correlate with the association with malignant tumours. The upstream regulatory sequences of HPVs 8, 19 and 25 appeared highly conserved but differed from those of previously sequenced papillomaviruses in length, in the TATA motif, in the copy numbers and positions of the ACCGN4CGGT palindrome and of a YGCCAA direct repeat, and in two strictly conserved blocks of 33 and 29 nucleotides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826651     DOI: 10.1099/0022-1317-68-12-3091

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  A highly conserved nucleotide string shared by all genomes of human papillomaviruses.

Authors:  J Campione-Piccardo; M L Montpetit; L Grégoire; M Arella
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

2.  Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.

Authors:  M T Chin; T R Broker; L T Chow
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region.

Authors:  A Ensser; H Pfister
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

4.  E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.

Authors:  F Stubenrauch; I M Leigh; H Pfister
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter.

Authors:  F Stubenrauch; H Pfister
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Late promoter of human papillomavirus type 8 and its regulation.

Authors:  F Stubenrauch; J Malejczyk; P G Fuchs; H Pfister
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes.

Authors:  B Akgül; W Lemme; R García-Escudero; A Storey; H J Pfister
Journal:  Arch Virol       Date:  2004-10-05       Impact factor: 2.574

8.  Characterization of novel cutaneous human papillomavirus genotypes HPV-150 and HPV-151.

Authors:  Anja Kovanda; Boštjan J Kocjan; Boštjan Luzar; Ignacio G Bravo; Mario Poljak
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

9.  Identification of a novel human papillomavirus by metagenomic analysis of vaginal swab samples from pregnant women.

Authors:  Zhijian Liu; Shixing Yang; Yan Wang; Quan Shen; Yan Yang; Xutao Deng; Wen Zhang; Eric Delwart
Journal:  Virol J       Date:  2016-07-04       Impact factor: 4.099

10.  Identification of a novel human papillomavirus by metagenomic analysis of samples from patients with febrile respiratory illness.

Authors:  John L Mokili; Bas E Dutilh; Yan Wei Lim; Bradley S Schneider; Travis Taylor; Matthew R Haynes; David Metzgar; Christopher A Myers; Patrick J Blair; Bahador Nosrat; Nathan D Wolfe; Forest Rohwer
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.